Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Kreitman

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Current Hematologic Malignancy Reports|July 30, 2013
Hairy cell leukemia-new genes, new targetsRobert J Kreitman
Expert Opinion on Biological Therapy|January 9, 2003
Recombinant fusion toxins for cancer treatmentRobert J Kreitman
Current Pharmaceutical Design|August 20, 2009
Recombinant immunotoxins for the treatment of chemoresistant hematologic malignanciesRobert J Kreitman
Nature Biotechnology|April 1, 2003
Taming ricin toxinRobert J Kreitman
Molecular Cancer Therapeutics|January 7, 2005
Confirmation and prevention of targeted toxicity by a recombinant fusion toxinRobert J Kreitman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 7, 2009
Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignanciesRobert J Kreitman
Idrugs : the Investigational Drugs Journal|December 24, 2003
Targeted therapies - First International CongressRobert J Kreitman
Current Opinion in Molecular Therapeutics|April 3, 2003
Recombinant toxins for the treatment of cancerRobert J Kreitman
Leukemia Research|July 19, 2011
Synergistic targeting of leukemia with leukotoxin and chemotherapyRobert J Kreitman
Expert Opinion on Biological Therapy|July 23, 2004
Recombinant immunotoxins for the treatment of haematological malignanciesRobert J Kreitman
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Current Hematologic Malignancy Reports|July 30, 2013
Hairy cell leukemia-new genes, new targetsRobert J Kreitman
Expert Opinion on Biological Therapy|January 9, 2003
Recombinant fusion toxins for cancer treatmentRobert J Kreitman
Current Pharmaceutical Design|August 20, 2009
Recombinant immunotoxins for the treatment of chemoresistant hematologic malignanciesRobert J Kreitman
Nature Biotechnology|April 1, 2003
Taming ricin toxinRobert J Kreitman
Molecular Cancer Therapeutics|January 7, 2005
Confirmation and prevention of targeted toxicity by a recombinant fusion toxinRobert J Kreitman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 7, 2009
Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignanciesRobert J Kreitman
Idrugs : the Investigational Drugs Journal|December 24, 2003
Targeted therapies - First International CongressRobert J Kreitman
Current Opinion in Molecular Therapeutics|April 3, 2003
Recombinant toxins for the treatment of cancerRobert J Kreitman
Leukemia Research|July 19, 2011
Synergistic targeting of leukemia with leukotoxin and chemotherapyRobert J Kreitman
Expert Opinion on Biological Therapy|July 23, 2004
Recombinant immunotoxins for the treatment of haematological malignanciesRobert J Kreitman
Pageof 15